.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Harvard Business School
QuintilesIMS
Argus Health
Mallinckrodt
Express Scripts
Covington
Deloitte
Chubb
Baxter

Generated: November 20, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: sinecatechins

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902NDAPharmaDerm a division of Fougera Pharmaceuticals Inc.10337-450-031 TUBE in 1 CARTON (10337-450-03) > 30 g in 1 TUBE
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902NDAPharmaDerm a division of Fougera Pharmaceuticals Inc.10337-450-081 TUBE in 1 CARTON (10337-450-08) > 2 g in 1 TUBE
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902NDAPharmaDerm a division of Fougera Pharmaceuticals Inc.10337-450-151 TUBE in 1 CARTON (10337-450-15) > 15 g in 1 TUBE
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902NDAPharmaDerm a division of Fougera Pharmaceuticals Inc.10337-450-991 TUBE in 1 CARTON (10337-450-99) > 4 g in 1 TUBE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Argus Health
Deloitte
Mallinckrodt
Chubb
Cipla
Daiichi Sankyo
Fish and Richardson
Harvard Business School

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot